A tripartite agreement concerning the action plan relating to 
a research project was signed on February 1, 2024 between
the MERINAL Laboratory, the Pharmaceutical Sciences Research Center (CRSP),
and the research laboratory oxidative stress kidney and 
associated pathologies ( University of Algiers 1).
This agreement aims to set up a research project to develop 
a useful therapeutic solution for the management of pathological situations linked to oxidative stress.
This agreement, signed by the directors of the three entities 
at the headquarters of MERINAL laboratories, is an original 
initiative aimed at combining the resources of 
the three partners in an ambitious research project with 
a specific pharmaceutical and health vocation and high
 added value.